Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Advances in Microarray Technology

Michael Pawlak's Biography

Michael Pawlak, Head, University of Tuebingen

Dr. Michael Pawlak joined the NMI in 2005 and is heading the Department of Biochemistry and Protein Profiling. In a multidisciplinary environment, scientists develop advanced assay systems and applications for industrial partners. Dr. Pawlak's research is focused on the application of microarrays for proteomic and cancer research, including the study of mechanisms of disease and drug action, and the identification of biomarkers for use in personalized medicine. He is offering protein profiling services to pharmaceutical industry and clinical research using Reverse Phase Protein Arrays for the analysis of protein signaling networks. Before Dr. Pawlak was at Novartis Pharma AG and co-founder of Zeptosens AG, and was pioneering sensitive planar waveguide technology for use with Reverse Phase Protein Arrays.

Michael Pawlak Image

RPPAs for Use in Drug Development and Clinical Research

Tuesday, 11 March 2014 at 14:00

Add to Calendar ▼2014-03-11 14:00:002014-03-11 15:00:00Europe/LondonRPPAs for Use in Drug Development and Clinical ResearchAdvances in Microarray Technology in Berlin, GermanyBerlin,

Reverse Phase Protein Arrays (RPPA) allow in-depth profiling of complex protein signaling networks from minute amounts of cellular samples. Obtained phenotype patterns and correlation to treatment response (on/off target, down-stream and cross-pathway signaling) provide a good mechanistic understanding of drug action and allow compound evaluation on a molecular basis. Examples of RPPA-based profiling will be presented.

Add to Calendar ▼2014-03-10 00:00:002014-03-11 00:00:00Europe/LondonAdvances in Microarray TechnologyAdvances in Microarray Technology in Berlin, GermanyBerlin,